JUDITH BERGMAN: Open Payments
NPI 1184617128 · PHOENIX, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$200 in 9 payments from 4 companies in 2025. Trend: 2023 $7,200 · 2024 $2,553 · 2025 $200
Food & beverage: $200
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 4 | $79 |
| ViiV Healthcare Company | 3 | $73 |
| Merck Sharp & Dohme LLC | 1 | $27 |
| Novo Nordisk Inc | 1 | $21 |
Products named: CABENUVA, PIFELTRO.
Industry payments across AZ — which companies pay providers there.
